H. Eriksson et al., EVIDENCE FOR THE KEY ROLE OF THE ADIPOCYTE CGMP-INHIBITED CAMP-PHOSPHODIESTERASE IN THE ANTILIPOLYTIC ACTION OF INSULIN, Biochimica et biophysica acta. Molecular cell research, 1266(1), 1995, pp. 101-107
Enhancement of cAMP degradation by increased cGMP-inhibited cAMP phosp
hodiesterase (cGI-PDE) activity is thought to be an important componen
t of the mechanism whereby insulin counteracts catecholamine-induced l
ipolysis in adipocytes. In this study the selective cGI-PDE inhibitor
OPC3911 was used to evaluate this role of cGI-PDE activation in intact
rat adipocytes with special reference to changes in cAMP levels measu
red as cAMP-dependent protein kinase (cAMP-PK) activity ratios. OPC391
1 completely blocked (IC50 = 0.3 mu M) the maximal inhibitory effect o
f insulin on noradrenaline-induced lipolysis and the net dephosphoryla
tion of hormone-sensitive lipase and other intracellular target protei
ns for insulin action, whereas insulin-induced lipogenesis was not cha
nged. The effect of OPC3911 on cAMP-PK activity ratios at different le
vels of lipolysis achieved by noradrenaline stimulation revealed that
the reduction of cAMP-PK caused by 1 nM insulin was completely blocked
by 3 mu M OPC3911. The effect of OPC3911 was not due to an excessive
increase in cellular cAMP resulting in 'supramaximal' lipolysis unresp
onsive to insulin. These data demonstrate that reduction in cAMP level
s by the activation of cGI-PDE may be sufficient to account for the an
tilipolytic action of insulin.